The 22nd China International In Vitro Diagnostic Expo (CACLP) took place from March 22-24, 2025, at the Hangzhou Grand Convention & Exhibition Center, Zhejiang. As a flagship event in the in vitro diagnostics (IVD) industry, CACLP serves as a vital platform for showcasing advancements and setting industry trends. This year’s exhibition attracted nearly 1,400 exhibitors and welcomed over 45,000 participants, underscoring its significance in the global IVD landscape.
Covering a wide array of topics, including clinical laboratory medicine, in vitro diagnostics, molecular diagnostics, PCR, POCT, biochemical immunology, and more, CACLP continues to be the barometer for the industry's development. Bioer Technology proudly participated in the event, presenting a suite of advanced molecular diagnostic solutions, including the AutoGene 9600 Automatic PCR Analysis System, Droplet Chip Digital PCR Analysis System, CentriDx Automated Nucleic Acid Analyzer, QuantGene/LineGene Fluorescent Quantitative Detection System, and GenePure Pro Nucleic Acid Purification System. Notably, this exhibition marked the domestic debut of the AutoGene 9600 Automatic PCR Analysis System, further demonstrating Bioer Technology’s commitment to innovation in automated molecular diagnostics.
Bioer Technology’s booth attracted significant interest from visitors, with numerous customers inquiring about its latest products and complementary reagents. In particular, there was strong enthusiasm for solutions in the areas of respiratory infections, reproductive health, and gastrointestinal infections, highlighting the growing demand for precise and efficient molecular diagnostic tools in these critical fields.
For over 20 years, Bioer Technology has been at the forefront of the life sciences and IVD industries, delivering high-quality instruments, reagents, and consumables that empower research and clinical diagnostics worldwide. With a strong focus on precision, efficiency, and reliability, the company has continuously contributed to advancements in molecular diagnostics. Looking ahead, Bioer Technology remains dedicated to driving innovation and expanding its portfolio of one-stop solutions, reinforcing its commitment to shaping the future of molecular diagnostics and life sciences.
